| Graft failure in the modern era of allogeneic hematopoietic SCT R Olsson, M Remberger, M Schaffer, DM Berggren, BM Svahn, J Mattsson, ... Bone marrow transplantation 48 (4), 537-543, 2013 | 335 | 2013 |
| Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysis S Carlens, O Ringden, M Remberger, B Lönnqvist, H Hägglund, ... Bone marrow transplantation 22 (8), 755-761, 1998 | 295 | 1998 |
| Graft failure after allogeneic hematopoietic cell transplantation J Mattsson, O Ringdén, R Storb Biology of blood and marrow transplantation 14 (1), 165-170, 2008 | 266 | 2008 |
| RESULTS OF DIFFERENT STRATEGIES FOR REDUCING CYTOMEGALOVIRUS-ASSOCIATED MORTALITY IN ALLOGENEIC STEM CELL TRANSPLANT RECIPIENTS1 P Ljungman, J Aschan, I Lewensohn-Fuchs, S Carlens, K Larsson, ... Transplantation 66 (10), 1330-1334, 1998 | 222 | 1998 |
| Risk factors for Epstein-Barr virus-related post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantation M Uhlin, H Wikell, M Sundin, O Blennow, M Maeurer, O Ringden, ... Haematologica 99 (2), 346, 2014 | 214 | 2014 |
| Low-intensity conditioning and hematopoietic stem cell transplantation in patients with renal and colon carcinoma P Hentschke, L Barkholt, M Uzunel, J Mattsson, P Wersäll, P Pisa, ... Bone marrow transplantation 31 (4), 253-261, 2003 | 172 | 2003 |
| Improved survival after allogeneic hematopoietic stem cell transplantation in recent years. A single-center study M Remberger, M Ackefors, S Berglund, O Blennow, G Dahllöf, A Dlugosz, ... Biology of Blood and Marrow Transplantation 17 (11), 1688-1697, 2011 | 170 | 2011 |
| Leukemia lineage-specific chimerism analysis is a sensitive predictor of relapse in patients with acute myeloid leukemia and myelodysplastic syndrome after allogeneic stem cell … J Mattsson, M Uzunel, L Tammik, J Aschan, O Ringden Leukemia 15 (12), 1976-1985, 2001 | 158 | 2001 |
| Incidence, risk factors, and outcome of bloodstream infections during the pre‐engraftment phase in 521 allogeneic hematopoietic stem cell transplantations O Blennow, P Ljungman, E Sparrelid, J Mattsson, M Remberger Transplant Infectious Disease 16 (1), 106-114, 2014 | 154 | 2014 |
| Rapid salvage treatment with virus-specific T cells for therapy-resistant disease M Uhlin, J Gertow, M Uzunel, M Okas, S Berglund, E Watz, M Brune, ... Clinical Infectious Diseases 55 (8), 1064-1073, 2012 | 154 | 2012 |
| Dose study of thymoglobulin during conditioning for unrelated donor allogeneic stem-cell transplantation M Remberger, BM Svahn, J Mattsson, O Ringdén Transplantation 78 (1), 122-127, 2004 | 151 | 2004 |
| Effect of total nucleated and CD34+ cell dose on outcome after allogeneic hematopoietic stem cell transplantation M Remberger, J Törlén, O Ringdén, M Engström, E Watz, M Uhlin, ... Biology of Blood and Marrow Transplantation 21 (5), 889-893, 2015 | 148 | 2015 |
| Poor oral nutrition after allogeneic stem cell transplantation correlates significantly with severe graft-versus-host disease J Mattsson, S Westin, S Edlund, M Remberger Bone Marrow Transplantation 38 (9), 629-633, 2006 | 140 | 2006 |
| The significance of graft-versus-host disease and pretransplantation minimal residual disease status to outcome after allogeneic stem cell transplantation in patients with … M Uzunel, J Mattsson, M Jaksch, M Remberger, O Ringdén Blood, The Journal of the American Society of Hematology 98 (6), 1982-1985, 2001 | 123 | 2001 |
| Risk factors for moderate-to-severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation M Remberger, G Kumlien, J Aschan, L Barkholt, P Hentschke, ... Biology of blood and marrow transplantation 8 (12), 674-682, 2002 | 122 | 2002 |
| Prenatal T-cell reconstitution after in utero transplantation with fetal liver cells in a patient with X-linked severe combined immunodeficiency M Westgren, O Ringdén, P Bartmann, TH Bui, B Lindton, J Mattsson, ... American journal of obstetrics and gynecology 187 (2), 475-482, 2002 | 119 | 2002 |
| T CELL MIXED CHIMERISM IS SIGNIFICANTLY CORRELATED TO A DECREASED RISK OF ACUTE GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION 1 J Mattsson, M Uzunel, M Remberger, O Ringdén Transplantation 71 (3), 433-439, 2001 | 116 | 2001 |
| Fetal membrane cells for treatment of steroid-refractory acute graft-versus-host disease O Ringden, T Erkers, S Nava, M Uzunel, E Iwarsson, R Conrad, ... Stem cells 31 (3), 592-601, 2013 | 112 | 2013 |
| Respiratory syncytial virus infection in recipients of allogeneic stem-cell transplantation: a retrospective study of the incidence, clinical features, and outcome G Avetisyan, J Mattsson, E Sparrelid, P Ljungman Transplantation 88 (10), 1222-1226, 2009 | 103 | 2009 |
| Targeted monitoring of patients at high risk of post‐transplant lymphoproliferative disease by quantitative Epstein–Barr virus polymerase chain reaction H Omar, H Hägglund, Å Gustafsson‐Jernberg, K LeBlanc, J Mattsson, ... Transplant infectious disease 11 (5), 393-399, 2009 | 103 | 2009 |
